ATE111353T1 - Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen. - Google Patents

Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.

Info

Publication number
ATE111353T1
ATE111353T1 AT90908603T AT90908603T ATE111353T1 AT E111353 T1 ATE111353 T1 AT E111353T1 AT 90908603 T AT90908603 T AT 90908603T AT 90908603 T AT90908603 T AT 90908603T AT E111353 T1 ATE111353 T1 AT E111353T1
Authority
AT
Austria
Prior art keywords
treatment
macrolids
reversible obstructive
obstructive airway
airway diseases
Prior art date
Application number
AT90908603T
Other languages
English (en)
Inventor
Alan Anthony Norris
Dale Michael Jackson
Sohei Makino
Takeshi Fukuda
Ikuo Akutsu
Original Assignee
Fisons Plc
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898912935A external-priority patent/GB8912935D0/en
Priority claimed from JP2096045A external-priority patent/JPH03291225A/ja
Application filed by Fisons Plc, Fujisawa Pharmaceutical Co filed Critical Fisons Plc
Application granted granted Critical
Publication of ATE111353T1 publication Critical patent/ATE111353T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT90908603T 1989-06-06 1990-06-06 Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen. ATE111353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898912935A GB8912935D0 (en) 1989-06-06 1989-06-06 Method of treatment
JP2096045A JPH03291225A (ja) 1990-04-09 1990-04-09 抗喘息薬

Publications (1)

Publication Number Publication Date
ATE111353T1 true ATE111353T1 (de) 1994-09-15

Family

ID=26295442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908603T ATE111353T1 (de) 1989-06-06 1990-06-06 Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.

Country Status (13)

Country Link
EP (1) EP0475994B1 (de)
JP (1) JP2508918B2 (de)
KR (1) KR0147852B1 (de)
AT (1) ATE111353T1 (de)
AU (1) AU639460B2 (de)
CA (1) CA2054203C (de)
DE (1) DE69012560T2 (de)
DK (1) DK0475994T3 (de)
ES (1) ES2061043T3 (de)
GR (1) GR1000738B (de)
IE (1) IE64214B1 (de)
PT (1) PT94292B (de)
WO (1) WO1990014826A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5147877A (en) * 1991-04-18 1992-09-15 Merck & Co. Inc. Semi-synthetic immunosuppressive macrolides
DE69231644T2 (de) * 1991-04-26 2001-05-23 Fujisawa Pharmaceutical Co Verwendung von makrolid-verbindungen gegen augenerkrankungen
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
AU2002952559A0 (en) * 2002-11-08 2002-11-21 Fujisawa Pharmaceutical Co., Ltd. New use
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
CA2552305A1 (en) * 2003-12-30 2005-07-14 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2020122611A1 (ko) * 2018-12-11 2020-06-18 이화여자대학교 산학협력단 신규 화합물 및 이를 포함하는 발모 촉진용 조성물
KR102293890B1 (ko) * 2018-12-11 2021-08-27 주식회사 몰젠바이오 신규 화합물 및 이를 포함하는 발모 촉진용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CH677448A5 (de) * 1987-11-09 1991-05-31 Sandoz Ag
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
CA2054203A1 (en) 1990-12-07
IE64214B1 (en) 1995-07-26
GR1000738B (el) 1992-12-30
DK0475994T3 (da) 1995-01-09
WO1990014826A1 (en) 1990-12-13
JPH05503283A (ja) 1993-06-03
AU639460B2 (en) 1993-07-29
PT94292B (pt) 1997-01-31
DE69012560T2 (de) 1995-03-09
DE69012560D1 (de) 1994-10-20
IE902002L (en) 1990-12-06
KR920700638A (ko) 1992-08-10
PT94292A (pt) 1991-02-08
CA2054203C (en) 2001-08-21
ES2061043T3 (es) 1994-12-01
EP0475994A1 (de) 1992-03-25
GR900100428A (en) 1991-11-15
EP0475994B1 (de) 1994-09-14
AU5721490A (en) 1991-01-07
KR0147852B1 (ko) 1998-08-17
JP2508918B2 (ja) 1996-06-19

Similar Documents

Publication Publication Date Title
ATE111353T1 (de) Makrolide zur behandlung reversibler obstruktiver atemwegserkrankungen.
HUP0402225A2 (hu) Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
TW243449B (de)
DE3570437D1 (en) 1-hydroxy-1,1-diphosphonic-acid derivatives, process for their preparation and pharmaceutical preparations, especially for the treatment of bone tumours
DE69704057T2 (de) Terphenylverbindungen und sie enthaltende arzneimittel
DK196688D0 (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
NO940777L (no) Anvendelse av et pregnanderivat
ATE239711T1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
DE3261515D1 (en) Benzopyranyl ethers, process for their preparation and medicine containing those compounds and intermediates
HUP0105426A2 (hu) 3-(2-oxo-[1,3']bipirrolidinil-3-ilidén-metil)-cefém-származékok és ezeket tartalmazó gyógyszerkészítmények
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
DE69907387D1 (de) Verwendung von Hydantoin-Derivaten zur Herstellung eines Medikaments zur Behandlung von refraktärer Vasculitis.
AU625238B2 (en) Anti-psychotic piperidylbenzimidazole compounds
AU655869B2 (en) An amphoteric tricyclic compound
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
IE780926L (en) Chromene derivatives
JPS55122767A (en) Imidazole derivative*its manufacture and medical composition containing it
HUT62890A (en) Process for producing benzothiazole derivatives and pharmaceutical compositions comprising such compounds
ATE198746T1 (de) Pyrimidinderivate und pharmazeutische zusammensetzungen
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
MX9601163A (es) Nuevos compuestos derivados de cromeno.
EP1291349A4 (de) Malto-oligosaccharide und deren verwendung
ATE109485T1 (de) Derivate von n-(vincristinyl-23) und n- (noranhydro-5-vinblastinyl-23) von amino-1- methylphosphonsäure, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee